SCHEMBL7540465

SCHEMBL7540465

Cc1cnc(C(=O)O)c(O)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
GRM5 P41594 2/20 0.36
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRE P78334 2/20 0.36
GABRA6 Q16445 2/20 0.36
GABRG1 Q8N1C3 2/20 0.36
GABRG3 Q99928 2/20 0.36
GABRQ Q9UN88 2/20 0.36
HCAR2 Q8TDS4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9592586 0.86 PKMYT1 (0.36) GRM5ALDH1A1
SCHEMBL24069013 0.83 ALDH1A1 (0.37) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL29432473 0.83 ALDH1A1 (0.41) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL6100470 0.83 ALDH1A1 (0.41) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL30206297 0.82 GRM5 (0.42) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL1674128 0.82 GRM5 (0.42) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL30112052 0.81 HPGD (0.39) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL7422568 0.81 HPGD (0.39) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL27479483 0.81 ALDH1A1 (0.40) KMT2AMEN1GRM5GABRPGABRD
SCHEMBL27559489 0.78 ALDH1A1 (0.37) KMT2AMEN1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109369545-B Synthesis process of 2-methyl-5-pyrazine formate 东营曜康医药科技有限公司 2020-04-10 CN claimed
US-5364940-A For treatment of sewage sludge with cultures LONZA LTD. (CH) 1994-11-15 US claimed
EP-0559116-A2 Microbiological process for the hydroxylation of nitrogen containing heterocyclic carbonic acids LONZA AG (CH) 1993-09-08 EP claimed
CN-109369545-B Synthesis process of 2-methyl-5-pyrazine formate 东营曜康医药科技有限公司 2020-04-10 CN disclosed
WO-2002029021-A2 BIOTECHNOLOGICAL METHOD FOR PREPARING CARBOXYLIC ACIDS WITH A HYDROXY-NITROGEN HETEROCYCLE LONZA AG (CH) 2002-04-11 WO disclosed
EP-0559116-B1 Microbiological process for the hydroxylation of nitrogen containing heterocyclic carbonic acids LONZA AG (CH) 1997-05-28 EP disclosed
US-5364940-A For treatment of sewage sludge with cultures LONZA LTD. (CH) 1994-11-15 US disclosed
US-5306630-A Microbiological process for hydroxylation of nitrogen-heterocyclic-carboxylic acids LONZA LTD. (CH) 1994-04-26 US disclosed
US-5250548-A Treating hypertension, heart failure ABBOTT LABORATORIES (US) 1993-10-05 US disclosed
EP-0559116-A2 Microbiological process for the hydroxylation of nitrogen containing heterocyclic carbonic acids LONZA AG (CH) 1993-09-08 EP disclosed
EP-0475206-A2 Angiotensin II receptor antagonists ABBOTT LABORATORIES (US) 1992-03-18 EP disclosed